A Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder.

Trial Profile

A Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2012

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Bipolar disorders; Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Nov 2010 Planned End Date changed from Dec 2009 to Dec 2011 as reported by ClinicalTrials.gov.
    • 30 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top